Lantern Pharma has won a trio of rare-pediatric-disease designations from the Food and Drug Administration for its investigational drug candidate LP-184 in multiple ultra-rare children's cancers.

A former "Real Housewives of Beverly Hills" star will be undergoing serious surgery after doctors found a tumor. The post ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer ...

The Barbara Ann Karmanos Cancer Institute welcomes Nithin Peddireddy, M.D., a head and neck surgical oncologist specializing ...

"I’m feeling strong and optimistic that this journey will soon be behind me with a positive outcome," Wiley told followers in ...

(LTRN) announced Monday that the company has been granted three rare pediatric disease designations (RPDD) by the FDA. Lantern was granted these rare pediatric disease designations in: malignant ...

The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

As with any type of tumor, brain tumors are an abnormal growth of cells, the number of which will determine, in part, the overall size of the tumor. In the case of benign brain tumors, these cells ...

Among cancer survivors, excess body weight is associated with an increased risk for a second primary malignant neoplasm, ...

Lab tests have found that bioactive glasses doped with the gallium have a 99% success rate of eliminating cancerous cells and ...

The findings, published in Nature Immunology, indicate that tumors edit the activity of multiple genes to avoid immune ...

Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy ...